Boston Scientific SYNERGY XD / MEGATRON
Everolimus stent with abluminal bioabsorbable polymer; MEGATRON for large vessels and left main.
Specifications
| Manufacturer | Boston Scientific — USA |
|---|---|
| Drug | Everolimus |
| Platform | Platinum-chromium |
| Strut thickness | 74 µm (SYNERGY XD) |
| Polymer | Abluminal bioabsorbable PLGA |
| Diameters | SYNERGY 2.25–4.00 mm; MEGATRON 3.50–5.00 mm |
| Procedures | PCI |
Specifications are compiled from public manufacturer information for education only. Always verify against the current IFU and the version registered in your country before clinical use.
Related products
XIENCE Skypoint
Everolimus stent with a fluoropolymer and one of the largest clinical evidence bases.
Drug: Everolimus
Onyx Frontier
Zotarolimus stent with Pt-Ir core for visibility; 2.0 mm size for small vessels.
Drug: Zotarolimus
Orsiro Mission
Ultrathin (60 µm) sirolimus stent with biodegradable polymer.
Drug: Sirolimus
Ultimaster Tansei
Sirolimus stent with abluminal gradient bioresorbable coating.
Drug: Sirolimus
Firehawk Liberty
Low-dose sirolimus stent with drug in recessed abluminal grooves.
Drug: Sirolimus (low dose, recessed abluminal grooves)
BioMime
Thin-strut sirolimus stent with hybrid cell design.
Drug: Sirolimus